Show simple item record

dc.contributor.authorDunn, Paul
dc.date.accessioned2022-01-19T11:28:05Z
dc.date.available2022-01-19T11:28:05Z
dc.date.issued2021-09-23
dc.identifier.citationPeacock, S., Briggs, D., Barnardo, M., Battle, R., Brookes, P., Callaghan, C., Clark, B., Collins, C., Day, S., Diaz Burlinson, N., Dunn, P., Fernando, R., Fuggle, S., Harmer, A., Kallon, D., Keegan, D., Key, T., Lawson, E., Lloyd, S., Martin, J., … Worthington, J. (2022). BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation. International journal of immunogenetics, 49(1), 22–29. https://doi.org/10.1111/iji.12558en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12904/15086
dc.description.abstractAll UK H&I laboratories and transplant units operate under a single national kidney offering policy, but there have been variations in approach regarding when to undertake the pre-transplant crossmatch test. In order to minimize cold ischaemia times for deceased donor kidney transplantation we sought to find ways to be able to report a crossmatch result as early as possible in the donation process. A panel of experts in transplant surgery, nephrology, specialist nursing in organ donation and H&I (all relevant UK laboratories represented) assessed evidence and opinion concerning five factors that relate to the effectiveness of the crossmatch process, as follows: when the result should be ready for reporting; what level of donor HLA typing is needed; crossmatch sample type and availability; fairness and equity; risks and patient safety. Guidelines aimed at improving practice based on these issues are presented, and we expect that following these will allow H&I laboratories to contribute to reducing CIT in deceased donor kidney transplantation.
dc.description.urihttps://onlinelibrary.wiley.com/doi/10.1111/iji.12558en_US
dc.language.isoenen_US
dc.subjectHLAen_US
dc.subjectantibodiesen_US
dc.subjectkidney transplantationen_US
dc.subjectvirtual crossmatchingen_US
dc.titleBSHI/BTS guidance on crossmatching before deceased donor kidney transplantationen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionVoRen_US
rioxxterms.versionofrecordhttps://doi.org/10.1111/iji.12558en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.dateFCD2022-01-19T11:28:05Z
refterms.versionFCDVoR
refterms.dateFOA2022-01-19T11:28:05Z
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2022-02
html.description.abstractAll UK H&I laboratories and transplant units operate under a single national kidney offering policy, but there have been variations in approach regarding when to undertake the pre-transplant crossmatch test. In order to minimize cold ischaemia times for deceased donor kidney transplantation we sought to find ways to be able to report a crossmatch result as early as possible in the donation process. A panel of experts in transplant surgery, nephrology, specialist nursing in organ donation and H&I (all relevant UK laboratories represented) assessed evidence and opinion concerning five factors that relate to the effectiveness of the crossmatch process, as follows: when the result should be ready for reporting; what level of donor HLA typing is needed; crossmatch sample type and availability; fairness and equity; risks and patient safety. Guidelines aimed at improving practice based on these issues are presented, and we expect that following these will allow H&I laboratories to contribute to reducing CIT in deceased donor kidney transplantation.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


Files in this item

Thumbnail
Name:
Peacock 2022.pdf
Size:
308.8Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record